Cargando…
New antibiotics for bad bugs: where are we?
Bacterial resistance to antibiotics is growing up day by day in both community and hospital setting, with a significant impact on the mortality and morbidity rates and the financial burden that is associated. In the last two decades multi drug resistant microorganisms (both hospital- and community-a...
Autores principales: | Bassetti, Matteo, Merelli, Maria, Temperoni, Chiara, Astilean, Augusta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3846448/ https://www.ncbi.nlm.nih.gov/pubmed/23984642 http://dx.doi.org/10.1186/1476-0711-12-22 |
Ejemplares similares
-
Siderophore–Antibiotic Conjugate Design: New Drugs for Bad Bugs?
por: Negash, Kokob H., et al.
Publicado: (2019) -
Aminoglycoside Resistance in ICUs: Are We Running out of Drugs, for Bad Bugs
por: Mojtahedzadeh, Mojtaba, et al.
Publicado: (2011) -
Exploring bacterial outer membrane barrier to combat bad bugs
por: Ghai, Ishan, et al.
Publicado: (2017) -
O088: Bad design, bad practices, bad bugs – Elizabethkingia meningoseptica outbreak in ICU
por: Salmon, S, et al.
Publicado: (2013) -
Good Bug, Bad Bug: What Is Influencing the Fever Response during Infection?
por: Kullberg, Robert F. J., et al.
Publicado: (2022)